Disclosure Panels Details Page
Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström Macroglobulinemia Panel - Disclosures as of 03/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Kehinde Adekola MD,MSCI | Blood and Marrow Transplant Clinical Trials Network - BMT CTN NHLBI Data and Safety Monitoring Board (DSMB) |
None | None | None | 01/19/2023 |
| Larry Anderson, Jr. PhD,MD | AbbVie, Inc. Bristol-Myers Squibb Company Cellectar GlaxoSmithKline Janssen Pharmaceutica Products, LP Prothena |
AbbVie, Inc. BeiGene Bristol-Myers Squibb Company Celgene Corporation Cellectar GlaxoSmithKline Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Oncopeptides Prothena sanofi-aventis U.S. |
AbbVie, Inc. BeiGene Bristol-Myers Squibb Company Celgene Corporation Cellectar GlaxoSmithKline Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Oncopeptides sanofi-aventis U.S. |
None | 01/14/2023 |
| Muhamed Baljevic MD | None | None | Bristol-Myers Squibb Company Cardinal Health CurioScience GlaxoSmithKline Janssen Biotech, Inc. Karyopharm Therapeutics NCCN 2022 Virtual Congress: Hematologic Malignancies Sanofi-Genzyme Targeted Oncology |
None | 01/29/2023 |
| Rachid Baz MD | AbbVie, Inc. arvinas Bristol-Myers Squibb Company Daiichi- Sankyo Co. Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Marker Therapeutics Pfizer Inc. pionyr immunotherapeutics quantum leap healthcare collaborative Regeneron Pharmactcls SeaGen Zymeworks |
Bristol-Myers Squibb Company GlaxoSmithKline |
advent health AHOMPR (Association of hematology oncology of Puerto Rico) Cancer Network Curio Science Hikma |
None | 02/01/2023 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Natalie Callander MD | None | None | None | None | 02/16/2023 |
| Erica Campagnaro MD | None | None | None | None | 02/03/2023 |
| Jorge Castillo MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Cellectar Eli Lilly and Company Pharmacyclics TG Therapeutics |
AbbVie, Inc. BeiGene Cellectar Janssen Pharmaceutica Products, LP Kite Pharma Pharmacyclics |
None | None | 02/06/2023 |
| Caitlin Costello MD | Multiple Myeloma Research Foundation | Celgene Corporation Janssen Pharmaceutica Products, LP Pfizer Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | 01/19/2023 |
| Christopher D'Angelo MD | BeiGene Bristol-Myers Squibb Company Fate Therapeutics |
AbbVie, Inc. Bristol-Myers Squibb Company Ono Pharma USA SeaGen |
None | None | 01/23/2023 |
| Srinivas Devarakonda MD | None | None | None | None | 01/13/2023 |
| Sarah DeVincenzo BCPS,PharmD | None | None | None | None | 01/03/2023 |
| Mary Dwyer MS | None | None | None | None | 12/19/2022 |
| Noura Elsedawy MD | GlaxoSmithKline | None | None | Vyriad | 03/17/2023 |
| Colleen Erb MSN,CRNP,AOCNP | None | None | None | None | 01/06/2023 |
| Alfred Garfall MD | CRISPR Therapeutics Janssen Pharmaceutica Products, LP Novartis Pharmaceuticals Corporation Tmunity Therapeutics |
Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP |
None | None | 01/23/2023 |
| Kelly Godby MD | None | None | None | None | 02/22/2023 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 12/12/2022 |
| Erin Hesler | None | None | None | None | 10/19/2022 |
| Jens Hillengass MD,PhD | Amgen Inc. Bristol-Myers Squibb Company Fate therapeutics Gilead Sciences, Inc. GlaxoSmithKline Harpoon Janssen Pharmaceutica Products, LP Pfizer Inc. Prothena sanofi-aventis U.S. |
Aptitude Health GlaxoSmithKline Intellisphere Janssen Pharmaceutica Products, LP Oncopeptides sanofi-aventis U.S. Skyline |
Amgen Inc. BeiGene Beijing Medical Award Foundation Curio Science Patient Partners Rapid Payer Response Research to Practice |
None | 01/04/2023 |
| Leona Holmberg PhD,MD | Bristol-Myers Squibb Company ITeos Janssen Pharmaceutica Products, LP Merck & Co., Inc. sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | Up-To-Date | 01/17/2023 |
| Myo Htut MD | Celgene Corporation Janssen Pharmaceutica Products, LP |
None | None | None | 02/02/2023 |
| Carol Ann Huff MD | Glenmark / Ichnos Prothena |
sanofi-aventis U.S. | None | None | 01/24/2023 |
| Malin Hultcrantz PhD,MD | AbbVie, Inc. Amgen Inc. BeiGene Daiichi- Sankyo Co. GlaxoSmithKline Springworks |
GlaxoSmithKline | GlaxoSmithKline | None | 02/18/2023 |
| Yubin Kang MD | Takeda Pharmaceuticals North America, Inc. | sanofi-aventis U.S. | None | None | 02/03/2023 |
| Rashmi Kumar PhD | None | None | None | None | 02/05/2023 |
| Shaji Kumar MD | AbbVie, Inc. Allogene Arcellx Bristol-Myers Squibb Company Carsgen GlaxoSmithKline Oncopeptides Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. |
AbbVie, Inc. Bluebird Bristol-Myers Squibb Company Epizyme GlaxoSmithKline Pfizer Inc. Regeneron Pharmaceuticals, Inc. Roche Laboratories, Inc. sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. Trillium |
None | None | 02/16/2023 |
| Sarah Larson MD | AbbVie, Inc. Allogene Bristol-Myers Squibb Company Celgene Corporation Janssen Pharmaceutica Products, LP Juno Therapeutics, Inc. Pfizer Inc. sanofi-aventis U.S. |
1200 Pharma TORL Biotherapeutics |
Oncovalent | None | 02/03/2023 |
| Hans Lee MD | Allogene Therapeutics Amgen Inc. Celgene Corporation Janssen Pharmaceutica Products, LP National Cancer Institute Regeneron Pharmaceuticals, Inc. Takeda Pharmaceuticals North America, Inc. |
Bristol-Myers Squibb Company Celgene Corporation Genentech, Inc. GlaxoSmithKline Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | 02/19/2023 |
| Michaela Liedtke MD | AbbVie, Inc. Allogene Bristol-Myers Squibb Company Caelum Gilead Sciences, Inc. Janssen Pharmaceutica Products, LP Seattle Genetics, Inc. |
Adaptive Bristol-Myers Squibb Company Janssen Pharmaceutica Products, LP Kite Pharma |
None | None | 01/16/2023 |
| Thomas Martin MD | Amgen Inc. Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Seattle Genetics, Inc. |
GlaxoSmithKline | Legend Biotech | None | 08/18/2022 |
| John Murphy | None | None | None | None | 01/03/2023 |
| James Omel MD | None | None | None | None | 12/14/2022 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 12/20/2022 |
| Aaron Rosenberg MD | Biomea GlaxoSmithKline Kangpu Biopharmaceuticals Sorento Takeda Pharmaceuticals North America, Inc. |
Kangpu Biopharmaceuticals | None | None | 02/28/2023 |
| Douglas Sborov MSc,MD | AbbVie, Inc. Gilead Sciences, Inc. GlaxoSmithKline Janssen Pharmaceutica Products, LP Pfizer Inc. sanofi-aventis U.S. |
AbbVie, Inc. Arcellx Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP Pfizer Inc. sanofi-aventis U.S. |
None | None | 02/16/2023 |
| Daniel Sherbenou PhD,MD | Karyopharm Therapeutics Pfizer Inc. sanofi-aventis U.S. |
None | None | None | 02/02/2023 |
| Jenna Snedeker MS,ASCP | None | None | None | None | 01/19/2023 |
| Attaya Suvannasankha MD | Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP Regeneron Pharmactcls SUTRO Biopharma, Inc. |
Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP |
None | None | 01/30/2023 |
| Jason Valent MD | AbbVie, Inc. Alexion Pharmaceuticals, Inc. Allogene therapeutics Amgen Inc. Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP Pfizer Inc. Pharmacyclics Prothena Biosciences |
None | None | none | 01/23/2023 |
| Asya Nina Varshavsky-Yanovsky MD,PhD | AbbVie, Inc. Bristol-Myers Squibb Company Gilead Sciences, Inc. GlaxoSmithKline Pfizer Inc. Takeda Pharmaceuticals North America, Inc. |
Bristol-Myers Squibb Company GlaxoSmithKline |
None | None | 10/26/2022 |